Coleman RL - Search Results

1

Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.

Westin SN, Sill MW, Coleman RL, Waggoner S, Moore KN, Mathews CA, Martin LP, Modesitt SC, Lee S, Ju Z, Mills GB, Schilder RJ, Fracasso PM, Birrer MJ, Aghajanian C. Westin SN, et al. Among authors: coleman rl. Gynecol Oncol. 2019 Dec;155(3):420-428. doi: 10.1016/j.ygyno.2019.09.024. Epub 2019 Oct 15. Gynecol Oncol. 2019. PMID: 31623857 Free PMC article. Clinical Trial.

2

Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.

Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Coleman RL, et al. Gynecol Oncol. 1994 Oct;55(1):29-35. doi: 10.1006/gyno.1994.1242. Gynecol Oncol. 1994. PMID: 7959262

3

Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer.

Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Levenback C, et al. Among authors: coleman rl. Gynecol Oncol. 2001 Nov;83(2):276-81. doi: 10.1006/gyno.2001.6374. Gynecol Oncol. 2001. PMID: 11606084 Clinical Trial.

4

Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.

Drake RD, Lin WM, King M, Farrar D, Miller DS, Coleman RL. Drake RD, et al. Among authors: coleman rl. Gynecol Oncol. 2004 Aug;94(2):320-4. doi: 10.1016/j.ygyno.2004.05.027. Gynecol Oncol. 2004. PMID: 15297168 Clinical Trial.

5

Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer.

Bhoola SM, Coleman RL, Herzog T, Morris R, Bryant C, Estes JM, Alvarez RD. Bhoola SM, et al. Among authors: coleman rl. Gynecol Oncol. 2004 Dec;95(3):564-9. doi: 10.1016/j.ygyno.2004.08.026. Gynecol Oncol. 2004. PMID: 15581964

6

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Rao GG, et al. Among authors: coleman rl. Gynecol Oncol. 2005 Jan;96(1):168-72. doi: 10.1016/j.ygyno.2004.09.009. Gynecol Oncol. 2005. PMID: 15589596 Clinical Trial.

7

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Coleman RL, et al. Gynecol Oncol. 2006 Apr;101(1):126-31. doi: 10.1016/j.ygyno.2005.09.041. Epub 2005 Nov 3. Gynecol Oncol. 2006. PMID: 16271384 Clinical Trial.

8

The role of maintenance therapy and novel taxanes in ovarian cancer.

Herzog TJ, Coleman RL, Markman M, Cella D, Thigpen JT. Herzog TJ, et al. Among authors: coleman rl. Gynecol Oncol. 2006 Aug;102(2):218-25. doi: 10.1016/j.ygyno.2005.12.001. Epub 2006 Feb 7. Gynecol Oncol. 2006. PMID: 16460787 Review.

9

Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.

Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Frumovitz M, et al. Among authors: coleman rl. Gynecol Oncol. 2007 Jan;104(1):100-3. doi: 10.1016/j.ygyno.2006.07.033. Epub 2006 Sep 11. Gynecol Oncol. 2007. PMID: 16963111 Clinical Trial.

10

Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.

Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DM. Crotzer DR, et al. Among authors: coleman rl. Gynecol Oncol. 2007 May;105(2):404-8. doi: 10.1016/j.ygyno.2006.12.024. Epub 2007 Feb 9. Gynecol Oncol. 2007. PMID: 17292461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters